FOLH1 and Familial prostate cancer: 3/29 (10.3%) were considered most likely prostate cancer metastases without PSMA expression, 7/29 (24.1%) suspicious for NPCaT, and 19/29 (65.5%) were determined most likely benign (Table 3).